INTERMITTENT VERSUS MAINTENANCE NEUROLEPTIC LONG-TERM TREATMENT IN SCHIZOPHRENIA - 2-YEAR RESULTS OF A GERMAN MULTICENTER STUDY

被引:68
作者
PIETZCKER, A
GAEBEL, W
KOPCKE, W
LINDEN, M
MULLER, P
MULLERSPAHN, F
TEGELER, J
机构
[1] UNIV DUSSELDORF,DEPT PSYCHIAT,D-40629 DUSSELDORF,GERMANY
[2] FREE UNIV BERLIN,DEPT PSYCHIAT,BERLIN,GERMANY
[3] UNIV GOTTINGEN,DEPT PSYCHIAT,GOTTINGEN,GERMANY
[4] UNIV MUNICH,DEPT PSYCHIAT,W-8000 MUNICH,GERMANY
[5] BIOMETR CTR THERAPEUT STUDIES,W-8000 MUNICH,GERMANY
关键词
D O I
10.1016/0022-3956(93)90059-B
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The paper presents the 2-year results of a multicenter study on the comparative efficacy of different neuroleptic long-term treatment strategies in 364 schizophrenic outpatients carried out by the German Neuroleptic Treatment Study (ANI) Group. Three randomly assigned open neuroleptic treatments were compared: standard prophylactic maintenance medication, and two types of intermittent treatment (early intervention and neuroleptic crisis intervention). Although relapserates were significantly lower under early intervention (49%) than under crisis intervention (63%), those under maintenance treatment were by far the lowest (23%). Dropout and rehospitalization rates under both intermittent treatment strategies were also significantly less favorable than under maintenance treatment, whereas psychopathology, social adjustment, subjective wellbeing, and side-effects were not significantly different between treatment strategies. Cumulative neuroleptic dosage was significantly lower under intermittent treatment, even when inpatient treatment in a case of rehospitalization was considered. In conclusion, prophylactic maintenance medication turns out again to be the best treatment for most of the patients.
引用
收藏
页码:321 / 339
页数:19
相关论文
共 49 条
[1]   MEASUREMENT OF FEELINGS USING VISUAL ANALOGUE SCALES [J].
AITKEN, RCB .
PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1969, 62 (10) :989-+
[2]   DRUG-THERAPY IN SCHIZOPHRENIA - VARIABILITY OF OUTCOME AND PREDICTION OF RESPONSE [J].
AWAD, AG .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1989, 34 (07) :711-720
[3]   DEPRESSIVE SYNDROMES IN SCHIZOPHRENIC-PATIENTS UNDER NEUROLEPTIC THERAPY [J].
BANDELOW, B ;
MULLER, P ;
FRICK, U ;
GAEBEL, W ;
LINDEN, M ;
MULLERSPAHN, F ;
PIETZCKER, A ;
TEGELER, J .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1992, 241 (05) :291-295
[4]  
CARPENTER W T JR, 1982, Psychopharmacology Bulletin, V18, P21
[5]   EARLY INTERVENTION, TIME-LIMITED, TARGETED PHARMACOTHERAPY OF SCHIZOPHRENIA [J].
CARPENTER, WT ;
HEINRICHS, DW .
SCHIZOPHRENIA BULLETIN, 1983, 9 (04) :533-542
[6]  
CARPENTER WT, 1990, AM J PSYCHIAT, V147, P1138
[7]  
CARPENTER WT, 1987, AM J PSYCHIAT, V144, P1466
[8]   INTERMITTENT MEDICATION FOR SCHIZOPHRENIC OUTPATIENTS - WHO IS ELIGIBLE [J].
CHILES, JA ;
STERCHI, D ;
HYDE, T ;
HERZ, MI .
SCHIZOPHRENIA BULLETIN, 1989, 15 (01) :117-121
[9]  
*COLL INT PSYCH SC, 1981, INT SKALEN PSYCHIATR
[10]   IMPORTANT ISSUES IN THE DRUG-TREATMENT OF SCHIZOPHRENIA [J].
DAVIS, JM ;
SCHAFFER, CB ;
KILLIAN, GA ;
KINARD, C ;
CHAN, C .
SCHIZOPHRENIA BULLETIN, 1980, 6 (01) :70-87